DrugPatentWatch Database Preview

Wyeth Pharms Pfizer Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH PHARMS PFIZER, and when can generic versions of WYETH PHARMS PFIZER drugs launch?

WYETH PHARMS PFIZER has one approved drug.

There are four US patents protecting WYETH PHARMS PFIZER drugs.

There are sixty-two patent family members on WYETH PHARMS PFIZER drugs in forty countries and ten supplementary protection certificates in nine countries.

Summary for Wyeth Pharms Pfizer

International Patents:	62
US Patents:	4
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Wyeth Pharms Pfizer

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Pfizer	DUAVEE	bazedoxifene acetate; estrogens, conjugated	TABLET;ORAL	022247-001	Oct 3, 2013		RX	Yes	Yes	7,683,051		Y	Y
Wyeth Pharms Pfizer	DUAVEE	bazedoxifene acetate; estrogens, conjugated	TABLET;ORAL	022247-001	Oct 3, 2013		RX	Yes	Yes	5,998,402		Y	Y
Wyeth Pharms Pfizer	DUAVEE	bazedoxifene acetate; estrogens, conjugated	TABLET;ORAL	022247-001	Oct 3, 2013		RX	Yes	Yes	6,479,535		Y
Wyeth Pharms Pfizer	DUAVEE	bazedoxifene acetate; estrogens, conjugated	TABLET;ORAL	022247-001	Oct 3, 2013		RX	Yes	Yes	8,815,934		Y

Expired US Patents for Wyeth Pharms Pfizer

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Pfizer	DUAVEE	bazedoxifene acetate; estrogens, conjugated	TABLET;ORAL	022247-001	Oct 3, 2013	7,138,392

Non-Orange Book US Patents for Wyeth Pharms Pfizer

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,835,729	2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
6,232,307	Tissue selective compounds in the treatment of ovarian cancer
6,127,404	Tissue selective compounds in the treatment of endometrial proliferation
6,787,538	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

International Patents for Wyeth Pharms Pfizer Drugs

Country	Document Number	Estimated Expiration
Taiwan	381093
New Zealand	314601
Slovakia	281737
Costa Rica	8615

Supplementary Protection Certificates for Wyeth Pharms Pfizer Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
608	Luxembourg		91608, EXPIRES: 20220415
0802183/01	Switzerland		PRODUCT NAME: BAZEDOXIFEN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58732 12.01.2010
2009 00035	Denmark
4	Finland

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Wyeth Ayerst
• Wyeth Cons
• Wyeth Pharms
• Wyeth Pharms Inc